updat
materi
concern
sever
acut
respiratori
syndrom
sar
appear
recent
issu
sever
journal
summar
aspect
report
alert
reader
particularli
sinc
one
might
expect
asthmat
individu
experi
greater
morbid
sar
infect
sar
appear
due
infect
novel
coronaviru
cv
usual
humaninfect
cv
strain
caus
cold
rare
caus
pneumonia
howev
animalstrain
cv
caus
extens
epidem
lower
respiratori
tract
diseas
livestock
poultri
current
evid
suggest
sarsassoci
cv
previous
unknown
cv
strain
probabl
origin
nonhuman
host
somehow
acquir
capac
infect
human
be
airborn
transmiss
larg
droplet
droplet
nuclei
appear
allow
cv
reach
alveoli
lead
high
incid
pneumonia
inform
publish
morbid
mortal
weekli
report
center
diseas
control
prevent
cdc
elsewher
given
updat
current
sar
case
unit
state
preval
accord
cdc
sar
case
worldwid
fatal
case
report
unit
state
individu
unit
state
suspect
sar
recent
travel
sarsinvolv
geograph
area
remain
patient
close
contact
suspect
sar
case
immedi
famili
job
health
care
worker
diagnosi
case
definit
sar
cdc
continu
use
clinic
manifest
fever
cough
dyspnea
histori
recent
travel
highrisk
geograph
area
andor
exposur
known
case
sar
suggest
laboratori
featur
includ
lymphopenia
thrombocytopenia
increas
serum
lactic
dehydrogenas
level
cdc
requir
abnorm
chest
radiograph
diagnosi
sar
world
health
organ
case
definit
includ
radiograph
abnorm
diagnost
test
time
specif
test
novel
cv
usual
avail
commun
laboratori
specimen
sarssuspect
case
sent
test
countyst
health
laboratori
cdc
accord
instruct
given
local
rtpcr
test
specif
rna
novel
cv
posit
sputum
specimen
obtain
within
first
day
onset
fever
patient
sar
result
test
neg
thereaft
cultur
techniqu
also
use
suitabl
equip
laboratori
studi
antibodi
level
novel
cv
must
carri
duplic
serum
specimen
second
specimen
obtain
least
day
onset
fever
travel
advisori
cdc
recommend
avoid
nonessenti
travel
china
hong
kong
hanoi
singapor
recent
travel
toronto
also
discourag
recent
travel
area
present
fever
cough
dyspnea
evalu
immedi
quarantin
indic
angioedema
uncommon
potenti
fatal
advers
reaction
treatment
angiotensinconvert
enzym
ace
inhibitor
drug
thought
due
increas
level
bradykinin
present
kininas
activ
ace
inhibit
howev
unclear
fewer
treat
ace
inhibitor
drug
manifest
angioedema
sometim
week
month
treatment
therefor
feasibl
identifi
individu
increas
risk
ace
inhibitorinduc
angioedema
appear
anoth
enzym
aminopeptidas
p
assum
major
role
catabol
bradykinin
activ
metabolit
ace
inhibit
studi
assess
mean
plasma
level
aminopeptidas
p
activ
hypertens
individu
previous
document
ace
inhibitorinduc
angioedema
level
nmolmlmin
significantli
lower
plasma
level
agesexmatch
hypertens
individu
previou
reaction
ace
inhibitor
treatment
nmolmlmin
level
normal
untreat
control
nmolmlmin
p
contrast
signific
differ
mean
plasma
level
carboxypeptidas
n
minor
catabol
bradykinin
studi
group
howev
author
found
correl
plasma
level
aminopeptidas
p
time
previou
initi
ace
inhibitor
therapi
onset
angioedema
episod
individu
patient
thu
predictor
angioedema
reactiv
ace
inhibitor
therapi
might
identifi
howev
still
unclear
variabl
time
onset
angioedema
occur
episod
ace
inhibitor
drug
taken
daili
investig
lymphocyt
respons
allergen
hinder
low
frequenc
circul
allergenspecif
lymphocyt
gener
assum
allergen
induc
h
respons
cultur
allergenspecif
clone
h
phenotyp
howev
analysi
allergenspecif
lymphocyt
nonallerg
individu
extens
examin
current
paper
investig
report
new
approach
use
carboxyfluorescein
succinimidyl
ester
csfe
detect
allergenspecif
lymphocyt
flow
cytometri
csfe
dye
equal
distribut
divid
cell
level
specif
indic
number
replic
cycl
cell
undergon
accordingli
investig
examin
csfelow
cell
cultur
medium
supplement
peanut
antigen
comparison
peanutallerg
individu
nonpeanutallerg
individu
individu
outgrown
peanut
allergi
reveal
interest
find
notabl
cell
peanutallerg
donor
show
h
polar
contrast
cell
individu
outgrown
allergi
cell
nonallerg
individu
show
h
cytokin
respons
peanut
antigen
similar
result
seen
lymphocyt
individu
egg
allergi
lymphocyt
cultur
ovalbumin
result
suggest
food
antigen
particular
peanut
antigen
intrins
induc
h
skew
type
respons
depend
donor
allerg
statu
find
lymphocyt
individu
outgrow
peanut
allergi
h
skew
suggest
shift
h
respons
h
respons
underli
clinic
toler
oral
administ
allergen
applic
novel
approach
examin
antigenspecif
cell
like
inform
develop
better
strategi
immunotherapi
effect
earlyonset
asthma
utero
exposur
matern
smoke
subsequ
childhood
lung
function
suggest
utero
exposur
matern
smoke
earli
onset
asthma
infanc
independ
associ
subsequ
chronic
decreas
lung
function
childhood
studi
compar
effect
factor
present
individu
combin
within
popul
particip
children
health
studi
predict
children
without
asthma
previous
expos
utero
matern
smoke
show
decreas
fev
forc
vital
capac
fvc
ratio
fef
among
children
without
prior
utero
exposur
matern
smoke
earlyonset
asthma
larger
decreas
fev
fev
fvc
fef
lateronset
asthma
howev
largest
decreas
pulmonari
function
seen
children
utero
tobacco
smoke
exposur
earlyonset
asthma
fev
fvc
decreas
approxim
fef
decreas
approxim
somewhat
surprisingli
signific
effect
postnat
environment
tobacco
smoke
exposur
alon
childhood
lung
function
find
suggest
possibl
addit
effect
utero
tobacco
exposur
earlyonset
asthma
childhood
lung
function
provid
evid
deleteri
effect
matern
smoke
pregnanc
smoke
pregnanc
might
particularli
harm
situat
child
born
articl
note
although
inhal
corticosteroid
icss
recommend
firstlin
therapi
moder
persist
asthma
still
debat
role
longterm
effect
icss
treatment
mild
persist
asthma
multiinstitut
studi
random
doubleblind
trial
carri
subject
age
year
countri
mild
persist
asthma
less
year
durat
previou
regular
treatment
icss
comparison
made
either
inhal
budesonid
adult
children
b
placebo
addit
preexist
asthma
therapi
end
studi
year
later
significantli
lower
frequenc
acut
asthma
exacerb
receiv
budesonid
treatment
treat
placebo
p
also
less
prn
asneed
use
system
corticosteroid
budesonidetr
subject
prebronchodil
fev
modestli
better
budesonidetr
individu
placebotr
individu
mean
year
year
p
postbronchodil
fev
also
better
budesonidetr
subject
effect
budesonid
treatment
independ
baselin
lung
function
well
type
baselin
medic
children
less
year
old
growth
rate
year
reduc
mean
cm
treat
budesonid
reduct
cm
occur
first
year
find
suggest
rel
earli
intervent
icss
decreas
risk
acut
asthma
flare
need
system
steroid
use
modestli
improv
airflow
function
remain
seen
whether
icsassoci
reduct
growth
veloc
persist
progress
igg
fc
receptor
r
complement
known
critic
effector
acut
inflammatori
respons
immun
complex
ic
exact
interact
key
compon
establish
present
studi
investig
use
mous
model
acut
pulmonari
icmedi
hypersensit
determin
interact
pathway
first
demonstr
knockout
anim
diminish
inflammatori
respons
ic
subsequ
local
express
alveolar
macrophag
show
administr
recombin
power
modul
express
particular
caus
upregul
downregul
inhibitori
receptor
furthermor
demonstr
express
acut
inflammatori
respons
kinet
correl
modul
result
establish
anaphylatoxin
major
regul
respons
lung
tolllik
critic
molecul
mediat
lpsinduc
neutrophil
respons
howev
exact
mechan
involv
defin
studi
investig
aim
determin
whether
express
neutrophil
resid
lung
cell
critic
neutrophil
recruit
use
adopt
bone
marrow
transfer
chimer
mice
express
either
leukocyt
lung
resid
cell
endotheli
cell
examin
contribut
express
particular
cell
surprisingli
system
lp
induc
dramat
increas
lung
neutrophilia
mice
lack
select
leukocyt
contrast
mice
lack
lung
resid
cell
endothelium
show
mark
reduct
neutrophil
sequestr
lung
find
challeng
convent
view
lp
directli
activ
neutrophil
trap
lung
result
suggest
instead
lp
effect
involv
far
complic
pathway
involv
signal
endotheli
cell
